Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

3D Transthoracic Echocardiographic Evaluation on Tricuspid Regurgitation Progression and Clinical Outcomes in Patients With Cardiac Implantable Electronic Device

NCT07793916 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT07793916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07793916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
3D Transthoracic Echocardiographic Evaluation on Tricuspid Regurgitation Progression and Clinical Outcomes in Patients With Cardiac Implantable Electronic Device
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Recruiting
Start date
January 22, 2026
Completion date
January 31, 2028
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cied implantation, leadless pacemaker, pacemaker, tricuspid regurgitation